AmCham Healthcare Committee Reviews Key Regulatory and Market Issues

On September 18, AmCham Kazakhstan’s Healthcare Committee brought together member companies for its quarterly meeting in Almaty.

The discussion focused on several regulatory and market-access issues currently affecting the healthcare sector in Kazakhstan, including:
• 𝗩𝗔𝗧 𝗼𝗻 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗶𝗰𝗲𝘀
• 𝗣𝗿𝗶𝗰𝗶𝗻𝗴 𝗮𝗻𝗱 𝗿𝗲𝗶𝗺𝗯𝘂𝗿𝘀𝗲𝗺𝗲𝗻𝘁 𝗺𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺𝘀
• 𝗙𝘂𝗻𝗱𝗶𝗻𝗴 𝗮𝗻𝗱 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝗰𝗰𝗲𝘀𝘀
• 𝗢𝗿𝗽𝗵𝗮𝗻 𝗱𝗿𝘂𝗴𝘀
• 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝘁 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗮𝗻𝗱 𝗹𝗼𝗰𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻
• 𝗜𝗣 𝗿𝗶𝗴𝗵𝘁𝘀

Members shared practical perspectives on implementing current regulations and identified areas where further clarification and coordinated engagement with government stakeholders may be needed.

The discussion also formed part of the Committee’s preparation for a 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗥𝗼𝘂𝗻𝗱𝘁𝗮𝗯𝗹𝗲 𝗽𝗹𝗮𝗻𝗻𝗲𝗱 𝗳𝗼𝗿 𝗹𝗮𝘁𝗲𝗿 𝘁𝗵𝗶𝘀 𝘆𝗲𝗮r, which will bring together the business community and government stakeholders to discuss key priorities for the sector.

We thank all Healthcare Committee members for their active participation and valuable contributions, and AstraZeneca 𝗳𝗼𝗿 𝗸𝗶𝗻𝗱𝗹𝘆 𝗵𝗼𝘀𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗺𝗲𝗲𝘁𝗶𝗻𝗴 𝗮𝘁 𝘁𝗵𝗲𝗶𝗿 𝗼𝗳𝗳𝗶𝗰𝗲.